R.O. Mirimanoff

Discipline

Psychologie (4) Economies et finances (3)

Type de document

Articles (19) Recensions (4)

Co-auteur

Date

Source

Mot-clé

Treatment (13) Radiotherapy (13) Patients (12) Cancer (12) Patients (12) cancer (11) Cancer (11) Radiotherapy (11) survie (9) Chemotherapy (9) Survival (9) Chemotherapy (9) Human beings (8) analyse (7) Methods (7) Methods (7) Analysis (7) maladie (6) adulte (6) Surgery (6) Tumors (6) Surgery (6) Prognosis (6) Months (6) Older people (6) Prognosis (6) adulte (6) maladie (6) Rates (5) Paper (5)

Documents écrit par R.O. Mirimanoff (19) | parle de R.O. Mirimanoff (0)

Prostate cancer: On the road of progress.
M. Bolla et al.
Outcomes of preoperative chemoradiotherapy followed by surgery in patients with unresectable locally advanced sigmoid colon cancer.
B. Qiu et al. (2016)
History of the rare cancer network and past research.
R.O. Mirimanoff et al. (2014)
The rare cancer network: ongoing studies and future strategy.
M. Ozsahin et al. (2014)
High-grade gliomas: reality and hopes.
R.O. Mirimanoff (2014)
Stereotactic body radiation therapy in stage I inoperable lung cancer: from palliative to curative options.
N. Boujelbene et al. (2013)
Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial.
M.E. Hegi et al. (2012)
The Rare Cancer Network: achievements from 1993 to 2012.
A. Patel et al. (2012)
Pure seminoma: A review and update.
N. Boujelbene et al. (2011)
Sequential or concomitant chemotherapy in limited stage small-cell lung cancer.
K. Khanfir et al. (2011)
Radiotherapy suppresses angiogenesis in mice through TGF-betaRI/ALK5-dependent inhibition of endothelial cell sprouting.
N. Imaizumi et al. (2010)
Feasibility and efficacy of accelerated weekly concomitant boost postoperative radiation therapy combined with concomitant chemotherapy in patients with locally advanced head and neck cancer.
B. Pehlivan et al. (2009)
Decrease in hemoglobin levels following surgery influences the outcome in head and neck cancer patients treated with accelerated postoperative radiotherapy.
B. Pehlivan et al. (2009)
Primary breast lymphoma: patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study.
W. Jeanneret-Sozzi et al. (2008)
The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study.
M. Mauer et al. (2007)
The reasons for discrepancies in target volume delineation : a SASRO study on head-and-neck and prostate cancers.
W. Jeanneret-Sozzi et al. (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R. Stupp et al.
External radiotherapy and anaemia treatment: state of the art.
M. Ozsahin et al. (8 janv. 2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma.
M.E. Hegi et al. (2005)